Development of CMI-977 as a potent and orally active 5-lipoxygenase inhibitor.

被引：0

作者：

Cai, X ^{[1
]}

Cheah, S ^{[1
]}

Chen, SM ^{[1
]}

Eckman, J ^{[1
]}

Ellis, J ^{[1
]}

Fisher, R ^{[1
]}

Fura, A ^{[1
]}

Grewal, G ^{[1
]}

Hussion, S ^{[1
]}

Ip, S ^{[1
]}

Killian, DB ^{[1
]}

LibertineGarahan, L ^{[1
]}

Lounsbury, H ^{[1
]}

Qian, CG ^{[1
]}

Scannell, RT ^{[1
]}

Yaeger, D ^{[1
]}

Wypij, DM ^{[1
]}

Yeh, CG ^{[1
]}

Young, MA ^{[1
]}

Yu, SX ^{[1
]}

机构：

[1] CYTOMED INC,CAMBRIDGE,MA 02139

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1997年 / 214卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：214 / MEDI

页数：1

共 50 条

[41] TEPOXALIN, AN ORALLY ACTIVE DUAL CYCLOOXYGENASE/5-LIPOXYGENASE INHIBTOR
FERRO, MP
ADAMS, RE
MART, AJ
WACHLER, MP
ARGENTIERI, DC
LEVINSON, SL
RITCHIE, DR
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 138 - MEDI
[42] Discovery of ucb 35440: A potent and orally active dual acting 5-lipoxygenase inhibitor and H1 receptor antagonist.
Cai, X
Arrington, M
Bayless, L
Eckman, J
Eckert, M
Ene, D
Ellis, J
Hussoin, S
Latham, M
Lewis, T
Libertine, L
Nicolas, JM
Scannell, R
Selig, W
Schwartz, E
Wels, B
Wypij, D
Young, M
Zou, D
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U62 - U62
[43] BILA 2157 BS (RI) is a potent, orally active renin inhibitor.
Panzenbeck, MJ
Madwed, J
Harrison, P
Weldon, SM
Kerr, S
Frei, P
Fogal, SE
Miner, E
Desai, S
Thibeault, D
Simoneau, B
Jung, GL
Lavallee, P
Anderson, PC
Winquist, RJ
FASEB JOURNAL, 1996, 10 (03): : 4030 - 4030
[44] Identification of a potent, orally active N2-isonicotinylpyrroloquinolone PDE5 inhibitor.
Fiordeliso, JJ
Lanter, JC
Walsh, SP
Sui, ZH
Macielag, MJ
Jiang, WQ
Guan, JH
Qiu, YH
Kraft, P
Lombardi, E
John, TM
Clancy, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U56 - U56
[45] TRI 50, a potent and selective orally active direct thrombin inhibitor.
Chahwala, SB
Dupe, R
Goddard, M
Esmail, A
Kakkar, VV
BLOOD, 2003, 102 (11) : 814A - 814A
[46] KINETICS AND MECHANISM OF DEGRADATION OF ZILEUTON, A POTENT 5-LIPOXYGENASE INHIBITOR
ALVAREZ, FJ
SLADE, RT
PHARMACEUTICAL RESEARCH, 1992, 9 (11) : 1465 - 1473
[47] Potent dual 5-lipoxygenase inhibitor and PAF receptor antagonist
Lloyd, AW
DRUG DISCOVERY TODAY, 1998, 3 (09) : 424 - 424
[48] SYNTHESIS OF CHIRAL ZILEUTON, A POTENT AND SELECTIVE INHIBITOR OF 5-LIPOXYGENASE
HSIAO, CN
KOLASA, T
TETRAHEDRON LETTERS, 1992, 33 (19) : 2629 - 2632
[49] INHIBITION OF LEUKOTRIENE BIOSYNTHESIS WITH A-53612, A SELECTIVE AND ORALLY ACTIVE INHIBITOR OF 5-LIPOXYGENASE (5-LO)
ALBERT, DH
DYER, R
YOUNG, PR
BARLOW, J
BORNEMEIER, D
BOUSKA, J
ROBERTS, E
SONSALLA, J
BROOKS, DW
CARTER, GW
FASEB JOURNAL, 1988, 2 (04): : A369 - A369
[50] SYNTHESIS OF CHIRAL ZILEUTON, A POTENT AND SELECTIVE INHIBITOR OF 5-LIPOXYGENASE
HSIAO, CN
KOLASA, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 442 - ORGN

← 1 2 3 4 5 →